Contraception News and Research

Latest Contraception News and Research

Focus on men in family planning programs

Scott Radloff, director of the Office of Population and Reproductive Health, writes about involving men in family planning on USAID's "Impact Blog."

21 Jun 2011

Celgene announces data from REVLIMID plus rituximab Phase II study on malignant lymphomas

Celgene International Sàrl announced that clinical data from a Phase II study, conducted by investigators from the MD Anderson Cancer Center in Houston, TX, evaluating the combination regimen of REVLIMID plus rituximab (R2) in untreated, advanced stage, indolent B-cell non-Hodgkin's lymphomas, were presented at the 11th International Conference on Malignant Lymphoma in Lugano, Switzerland.

18 Jun 2011

Celgene, GELA to conduct REVLIMID/rituximab combination study on newly diagnosed FL

Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Celgene International Sarl today announced a collaboration to conduct an international randomized study to evaluate the therapeutic potential of the REVLIMID/rituximab combination regimen (R2) in patients with newly diagnosed follicular lymphoma.

17 Jun 2011

REVLIMID-R-CHOP Phase I/II data in untreated DLBCL presented at malignant lymphoma conference

Celgene International Sàrl announced that clinical data from two studies evaluating the use of REVLIMID® (lenalidomide) with standard R-CHOP chemotherapy in patients with untreated diffuse large B cell (DLBCL) or grade 3 follicular lymphoma were presented at the 11th International Conference on Malignant Lymphoma in Lugano, Switzerland.

17 Jun 2011

Viewpoints: Medicare eligibility age; Medicare 'scares'; questions about Fla. Medicaid managed care

The bottom line is that we probably need to start raising Medicare's eligibility age incrementally, given today's life-expectancy realities. But it is not going to be the silver bullet that saves Medicare.

17 Jun 2011

State roundup: Mass. health spending's rise; huge Ky. hospital merger

A new report from the state Division of Health Care Finance and Policy shows that: ... "Spending per member on privately insured people grew 6 percent from 2007 to 2008 and another 10 percent from 2008 to 2009. This rate of growth was substantially higher than the increase in national personal health care expenditures per capita of 4.6 percent from 2008 to 2009. Spending by private payers also grew faster than spending by public payers".

16 Jun 2011

Less-invasive Pro-Vas occlusion shows promise for permanent male sterilization

A new clinical study presented at the American Urological Association (AUA) Annual Meeting shows the less-invasive Pro-Vas occlusion as a highly promising method of permanent male sterilization.

9 Jun 2011

Combined contraceptive pill does not cause weight gain in young women

Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.

8 Jun 2011

Dacogen Phase III study results on acute myeloid leukemia presented at ASCO 2011

Results from the DACO-016 trial of Dacogen (decitabine) in acute myeloid leukemia (AML) were presented today at the 2011 Annual Meeting of the American Society of Clinical Oncology (ASCO)

7 Jun 2011

Celgene announces results of REVLIMID, docetaxel/prednisone phase II combination study on mCRPC

Celgene International Sàrl today announced results from a phase II investigator initiated study of REVLIMID (lenalidomide) in combination with Avastin (bevacizumab), docetaxel and prednisone in patients with metastatic castration-resistant prostate cancer were presented at the 2011 American Society of Clinical Oncology Annual Meeting in Chicago, Ill.

6 Jun 2011

Safety of birth control pills under scrutiny

Bayer’s oral contraceptive pills are being reviewed by regulators after some studies suggested they may cause more blood clots than competing medicines.

5 Jun 2011

Birth control pill safety issues raised

The U.S. Food and Drug Administration (FDA) has announced that it is looking at results from two studies that showed there is a higher risk of blood clots in women taking new birth control pills containing the compound drospirenone. Some brand names include Yaz, Yasmin, Beyaz, Ocella, Loryna, Gianvi, Safyral, Syeda and Zarah.

1 Jun 2011

Vatican newspaper article addresses condom use among married couples

Three days before the start of a Vatican conference focusing on "the centrality of care" in HIV/AIDS prevention and treatment, the Vatican's official newspaper, L'Osservatore Romano, on Tuesday printed a piece by Spanish theologian Juan Jose Perez-Soba arguing that married couples with one HIV-positive partner "should abstain from sex, because intercourse performed with a condom is, 'from the moral point of view, not a fully conjugal act,'" RNS/Beliefnet News reports.

26 May 2011

16 Countries announce new commitments to reduce maternal, newborn and child mortality

Today 16 countries announced new commitments to dramatically reduce maternal, newborn and child mortality, as part of the Global Strategy for Women's and Children's Health.

21 May 2011

Merck's VICTRELIS receives European CHMP positive opinion for treatment of chronic HCV genotype 1 infection

Merck, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion under accelerated assessment recommending approval of the investigational medicine VICTRELIS (boceprevir) for the treatment of chronic hepatitis C virus genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients with compensated liver disease who are previously untreated or who have failed previous therapy.

20 May 2011

Critics say program offering money for contraception to HIV-positive Kenyan women is illegal

IRIN/Plus News reports that "the Kenyan government and rights groups have expressed outrage at a project in western Kenya that is paying HIV-positive women to undergo long-term contraception."

17 May 2011

Report calls for developing new methods of contraception for women in developing countries

Women in the developing world need new methods of contraception that meet their needs and lifestyles, according to a Guttmacher Institute report that urges more investment in contraceptive technology, Agence France-Presse reports.

16 May 2011

New circumcision treatment can reduce HIV

Promising study results published in the May issue of JAIDS show that a novel medical device has the potential to revolutionize how male circumcision services are offered in countries hardest hit by the HIV epidemic.

13 May 2011

Starpharma inks licence agreement in Japan with Okamoto for VivaGel-coated condoms

Starpharma Holdings Limited today announced that it has signed a licence agreement with Okamoto Industries Inc in relation to the VivaGel(r)-coated condom for the Japanese market. Okamoto is the market leader for condoms sold in Japan, the world's second largest condom market.

10 May 2011

U.N. report forecasts global population increases through 2100

The world's population "is expected to grow from nearly 6.9 billion currently to 9.3 billion by 2050 and 10.1 billion by 2100," the U.N. said in a report on Tuesday, the Associated Press reports, noting that the U.N. uses the projections "to devise and fund programs for problems ranging from climate change to maternal mortality".

5 May 2011

Contraception News and Research

Latest Contraception News and Research

Focus on men in family planning programs

Celgene announces data from REVLIMID plus rituximab Phase II study on malignant lymphomas

Celgene, GELA to conduct REVLIMID/rituximab combination study on newly diagnosed FL

REVLIMID-R-CHOP Phase I/II data in untreated DLBCL presented at malignant lymphoma conference

Viewpoints: Medicare eligibility age; Medicare 'scares'; questions about Fla. Medicaid managed care

State roundup: Mass. health spending's rise; huge Ky. hospital merger

Less-invasive Pro-Vas occlusion shows promise for permanent male sterilization

Combined contraceptive pill does not cause weight gain in young women

Dacogen Phase III study results on acute myeloid leukemia presented at ASCO 2011

Celgene announces results of REVLIMID, docetaxel/prednisone phase II combination study on mCRPC

Safety of birth control pills under scrutiny

Birth control pill safety issues raised

Vatican newspaper article addresses condom use among married couples

16 Countries announce new commitments to reduce maternal, newborn and child mortality

Merck's VICTRELIS receives European CHMP positive opinion for treatment of chronic HCV genotype 1 infection

Critics say program offering money for contraception to HIV-positive Kenyan women is illegal

Report calls for developing new methods of contraception for women in developing countries

New circumcision treatment can reduce HIV

Starpharma inks licence agreement in Japan with Okamoto for VivaGel-coated condoms

U.N. report forecasts global population increases through 2100

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Contraception News and Research

Latest Contraception News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in